Fundraising FoxBioCardia
NASDAQ: BCDASan Carlos, US · Delaware corporation
Find your way into BioCardia
Sign up to see every warm intro you have to BioCardia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioCardia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioCardia develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases, with a lead program targeting ischemic heart failure with reduced ejection fraction. Its work centers on autologous cell therapy delivered through clinical trials.
Founders & leadership
SH
SIMON H. STERTZERFounder
RT
RICHARD T. ALLENExecutive
PA
Peter AltmanCEOPeter Altman is president and CEO of BioCardia, which develops autologous cell therapies for cardiovascular and pulmonary diseases. He brings experience from leadership roles in biotechnology, diagnostics, and medical devices, with expertise in clinical development, regulatory strategy, and business development.
DM
David McClungChief Financial OfficerChief Financial Officer of BioCardia, a cellular therapeutics company developing treatments for cardiovascular and pulmonary diseases. McClung brings experience in finance spanning private industry and public accounting across public and private organizations, with particular focus on early and mid-stage companies.
Board
AR
ALLAN R, TESSLERBoard director
RK
RICHARD KRASNOBoard director
FL
FERNANDO L. FERNANDEZBoard director
JM
TQ
THOMAS QUERTERMOUSBoard director
RC
RICHARD C. PFENNIGER, JRBoard director
Funding
SEC filings, press & company announcements$44.3M disclosed across 3 rounds · 2016–2026
- $4.4MraisedJun 2026 · 4 sourcesSource ↗
▶$4MraisedJan 2019 · 3 investors · BiotechnologyRule 506(b)
▶$4MraisedJan 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard C. PfennigerDirector
- Allan R. TesslerDirector
- Richard KrasnoDirector
- Thomas QuertermousDirector
- Simon StertzerDirector
- Fernando L. FernandezDirector
- David McClungExecutive Officer
- Peter AltmanExecutive Officer, Director
- Jay M. MoyesDirector
- Offering amount
- $4M
- Amount sold
- $4M
- Sales commissions
- $200K
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35.9MraisedNov 2016 · 192 investors · Other Health CareRule 506(b)
▶$35.9MraisedNov 2016 · 192 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- RICHARD KRASNODirector
- FERNANDO L. FERNANDEZDirector
- JAY M. MOYESDirector
- PETER ALTMANExecutive Officer, Director, Promoter
- SIMON H. STERTZERDirector
- THOMAS QUERTERMOUSDirector
- ALLAN R, TESSLERDirector
- PHIL PESTAExecutive Officer
- RICHARD C. PFENNIGER, JRDirector
- RICHARD T. ALLENExecutive Officer
- ERIC DUCKERSExecutive Officer
- DAVID MCCLUNGExecutive Officer
- Offering amount
- $35.9M
- Amount sold
- $35.9M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$24.4Mvaluation at IPOJun 2020 · $2.10/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Frequently asked questions
- What does BioCardia do?
- BioCardia develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases, with a lead program targeting ischemic heart failure with reduced ejection fraction. Its work centers on autologous cell therapy delivered through clinical trials.
- Who founded BioCardia?
- BioCardia was founded by SIMON H. STERTZER.
- How much funding has BioCardia raised?
- BioCardia has disclosed $44.3M raised across 3 rounds.
- Where is BioCardia headquartered?
- BioCardia is headquartered in San Carlos, US.